approval
saveADLYXIN (LIXISENATIDE) — FDA approval
community read0 votes
Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalADLYXIN (LIXISENATIDE) — FDA approvalMay 28, 2025 · 499d ago
- approvalADLYXIN (LIXISENATIDE) — FDA approvalNov 1, 2024 · 707d ago
- approvalADLYXIN (LIXISENATIDE) — FDA approvalSep 28, 2023 · 1107d ago
- approvalADLYXIN (LIXISENATIDE) — FDA approvalJun 10, 2022 · 1582d ago
- approvalADLYXIN (LIXISENATIDE) — FDA approvalJul 30, 2021 · 1897d ago
- approvalADLYXIN (LIXISENATIDE) — FDA approvalJul 27, 2016 · 3726d ago
same company · ±60 days · 5
- approvalToujeo LA: SOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalMar 12, 2026
- approvalteriflunomide: AUBAGIO (TERIFLUNOMIDE) — FDA approvalFeb 11, 2026
- approvalprimaquine phosphate: PRIMAQUINE (PRIMAQUINE PHOSPHATE) — FDA approvalFeb 2, 2026
- drug shortageRifampin Injection shortage — Sanofi-Aventis U.S. LLCApr 20, 2026
- approvalrifapentine: PRIFTIN (RIFAPENTINE) — FDA approvalJan 27, 2026
comments(0)
5-min edit window · permanent after that